Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hodgkin Disease 50Lymphoma 45Testicular Neoplasms 13Teratoma 12HIV Infections 12Acquired Immunodeficiency Syndrome 11Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Non-Hodgkin 9Head and Neck Neoplasms 8Endodermal Sinus Tumor 8Testicular Germ Cell Tumor 7Sarcoma, Kaposi 7Neoplasms 7Carcinoma, Embryonal 7Seminoma 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Ovarian Neoplasms 5Ovarian Germ Cell Cancer 5Recurrence 4Neoplasms, Germ Cell and Embryonal 4Neoplasm Metastasis 4Carcinoma, Squamous Cell 4Vulvar Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Breast Neoplasms 3Teratoma, Testicular 2Skin Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Drug-Related Side Effects and Adverse Reactions 2

Interventions

Gemcitabine 685130-nm albumin-bound paclitaxel 199Fluorouracil 190Oxaliplatin 177Albumin-Bound Paclitaxel 154Capecitabine 137Leucovorin 133Irinotecan 114Radiotherapy 96Taxes 85pembrolizumab 81Cisplatin 73Erlotinib Hydrochloride 70Radiosurgery 69Nivolumab 56Drug Therapy 56Bevacizumab 54Magnetic Resonance Spectroscopy 51Cyclophosphamide 50folfirinox 45Specimen Handling 43Docetaxel 42Cetuximab 40Biopsy 39irinotecan sucrosofate 38S 1 (combination) 36Pancreaticoduodenectomy 35Blood Specimen Collection 34Surgical Procedures, Operative 31Paclitaxel 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Bleomycin × Clear all
NCT00027521 2012-09-19

Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer

Ichor Medical Systems Incorporated

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡